Dieulafoy's lesion
Dieulafoy's lesion | |
---|---|
Other names | Exulceratio simplex Dieulafoy |
epinephrine injection, etc | |
Prognosis | 8% mortality[1] |
Frequency | 1.5% of gastrointestinal bleeding |
Dieulafoy's lesion (French:
Signs and symptoms
Dieulafoy's lesion often do not cause symptoms (asymptomatic). When present, symptoms usually relate to painless bleeding, with vomiting blood (
Presenting Symptoms | |
---|---|
Recurrent hematemesis with melena | 51% of cases |
Hematemesis without melena | 28% of cases |
Melena without hematemesis | 18% of cases |
Though exceptionally rare, cases of Dieulafoy lesions occurring in the gallbladder can cause upper abdominal pain, which is usually right upper quadrant or upper middle (
Cause
In contrast to peptic ulcer disease, a history of
Pathophysiology
Dieulafoy lesions are characterized by a single abnormally large blood vessel (arteriole) beneath the gastrointestinal mucosa (submucosa) that bleeds,[8] in the absence of any ulcer, erosion, or other abnormality in the mucosa. The size of these blood vessels varies from 1–5 mm (more than 10 times the normal diameter of mucosal capillaries). Pulsation from the enlarged vessels leads to focal pressure that causes thinning of the mucosa at that location, leading to exposure of the vessel and subsequent hemorrhage.[1]
Approximately 75% of Dieulafoy's lesions occur in the upper part of the stomach within 6 cm of the
Dieulafoy's lesions have been reported in the gallbladder. The pathology in these extragastric locations is essentially the same as that of the more common gastric lesion.Diagnosis
A Dieulafoy's lesion is difficult to diagnose, because of the intermittent pattern of bleeding. Dieulafoy's lesion are typically diagnosed during endoscopic evaluation, usually during
Treatment
In most cases, Dieulafoy lesions are treated with endoscopic interventions. Endoscopic techniques used in the treatment include
In cases of refractory bleeding, interventional radiology may be consulted for an angiogram with subselective embolization.[10]
Prognosis
The mortality rate for Dieulafoy's was much higher before the era of endoscopy, where open surgery was the only treatment option. Mortality has decreased from 80% to 8% as a result of endoscopic therapies.[1] Long term control of bleeding (hemostasis) is achieved in 85 - 90 percent of cases.
Epidemiology
Dieulafoy's lesions account for roughly 1.5 percent of gastrointestinal hemorrhage.[11] These lesions are twice as common in men, and often occur in older individuals (over 50 years of age) with multiple comorbidities, including hypertension, cardiovascular disease, chronic kidney disease, and diabetes. Dieulafoy's lesions present in individuals with an average age of 52 years.[1]
History
Dieulafoy's lesion was first described in 1884 by M.T. Gallard.[11] The lesion was named after French surgeon Paul Georges Dieulafoy, who described the condition in his paper "Exulceratio simplex: Leçons 1-3" in 1898.[11][5][6] Dieulafoy believed (incorrectly) the bleeding from this lesion was due to erosions of the mucosa in the stomach.[11]
References
- ^ ISBN 0323609627.
- ISSN 0003-4932.
- ^ PMID 10453143.
- PMID 17237996.
- ^ Who Named It?
- ^ a b G. Dieulafoy. Exulceratio simplex: Leçons 1-3. In: G. Dieulafoy, editor: Clinique medicale de l'Hotel Dieu de Paris. Paris, Masson et Cie: 1898:1-38.
- ^ PMID 29477106.
- PMID 2210260.
- PMID 12872092.
- PMID 23997409.
- ^ PMID 28062437.